Categories AlphaGraphs, Earnings, Health Care
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also exceeded Wall Street’s projection.
At $3.33 per share, September-quarter adjusted earnings were higher than $2.83 per share reported in the prior-year quarter and slightly above the consensus estimates. Net income, including special items, was $3.18 billion or $1.78 per share, compared to $2.31 billion or $1.29 per share in the third quarter of 2020.
Driving the bottom-line growth, net revenues increased 11% year-over-year to $14.34 billion. Market watchers were looking for slightly slower growth.
Read management/analysts’ comments on AbbVie’s Q3 results
AbbVie’s shares made modest gains on Friday morning following the earnings announcement, after closing the previous session higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was